報價延遲最少15分鐘:2025/08/10 15:54 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
29.21 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-13.22/--
|
|
企業價值
89.04M
|
| 資產負債 |
|
每股賬面淨值
1.67
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/08/10 15:54 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property. |
